Comment on "Sirolimus use and risk of cutaneous squamous cell carcinoma (SCC) in solid organ transplant recipients (SOTRs)"

J Am Acad Dermatol. 2016 May;74(5):e105-6. doi: 10.1016/j.jaad.2015.11.052.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Carcinoma, Squamous Cell / epidemiology*
  • Female
  • Humans
  • Immunosuppressive Agents / administration & dosage*
  • Male
  • Organ Transplantation / adverse effects*
  • Sirolimus / administration & dosage*
  • Skin Neoplasms / epidemiology*
  • Transplant Recipients / statistics & numerical data*

Substances

  • Immunosuppressive Agents
  • Sirolimus